-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Initiates Coverage On Ascentage Pharma Group with Buy Rating, Announces Price Target of $51

Benzinga·11/24/2025 17:50:30
Listen to the news
Truist Securities analyst Gregory Renza initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Buy rating and announces Price Target of $51.